------------------------ Yahoo! Groups Sponsor --------------------~--> 
Get fast access to your favorite Yahoo! Groups. Make Yahoo! your home page
http://us.click.yahoo.com/dpRU5A/wUILAA/yQLSAA/H4xqlB/TM
--------------------------------------------------------------------~-> 

Scientists Allege U.S. Losing Lead in Stem Cell Research; Advanced 
Cell Technology Generated Stem Cell Embryos in 2003, but Lack of 
Federal Funding Hampered Progress 

  
Figure Cloned Human Morula : A human embryo generated by SCNT at 
Advanced Cell Technology in 2003 (Photo: Business Wire). 

Nov. 23, 2005--South Korea's World Stem Cell Hub could become the 
leading center for stem cell and therapeutic cloning research, 
because of the chilling effect U.S. policy has had on stem cell 
research, according to Dr. Robert Lanza, Vice President for Medical 
& Scientific Development of Advanced Cell Technology, Inc. (OTCBB: 
ACTC), and Professor Ronald Green, Director of Dartmouth's Ethics 
Institute and chair of Advanced Cell Technology's Ethics Advisory 
Board, writing in the November 24th issue of the scientific journal 
Nature. "It reflects how far the United States has fallen behind its 
competitors in this pivotal area and how much the lack of federal 
leadership has handicapped US efforts," allege Lanza and Green. 


The current administration's restrictive policy also impacted 
Advanced Cell Technology's own promising program to produce human 
embryos through somatic cell nuclear transfer (SCNT), Lanza and 
Green state. "We believe the South Koreans are winning the race, 
because "in our view (the current administration's) restrictive 
policy on funding stem cell research was a major factor." They add, 
that the Administration "repeatedly spoke out in support of 
legislation in Congress that would ban all therapeutic cloning 
research." 

Advanced Cell Technology's own human SCNT program was initiated in 
2000, with strong ethical guidelines provided by the company's 
Ethics Advisory Board to assist researchers in this pioneering egg 
donor program. 

"Apart from the egos involved here," said Green, "the stakes for 
this research are important. Although the South Korean team deserves 
every credit for their accomplishments, the current absence of a 
strong U.S. competitor in this research narrows the range of 
directions likely to be explored." 

"By driving research out of this country, (U.S. government) policies 
have also made it difficult to develop and apply rigorous ethical 
oversight for this research," Green added. 

After Advanced Cell Technology scientists created the first early (4-
6 cell stage) cloned human embryos in 2001, they were able to 
quickly generate more advanced stem-cell-competent stage embryos. In 
the last SCNT experiments in 2003, the company had 16 eggs, of which 
13 (81%) developed into healthy-looking 8-16 cell morula, which have 
the capacity to generate stem cells in both animals and humans. 

Advanced Cell Technology carried out control experiments involving 
just activation. Although healthy looking in appearance, both the 
SCNT embryos and parthenote controls failed to develop into 
blastocysts, because the wrong culture media were being used. When 
the company's scientists changed the media and repeated the 
parthenote controls the next time, 12 of 14 (86%) 8-16 cell stage 
morula went on to develop into blastocysts. 

"As early as 2002 and 2003," Lanza said, "the Advanced Cell 
Technology research team had the science worked out and simply 
needed to repeat the experiment using the right media in order to 
obtain stem cells. Unfortunately, these were the last SCNT 
experiments performed in the Unite States." 

Lanza and Green conclude by noting that the company was not a 
special case. "Indeed, the stem-cell area as a whole has continued 
to encounter difficulties in garnering sufficient financial 
support." 

About Advanced Cell Technology 

Advanced Cell Technology, Inc. is a biotechnology company applying 
stem cell technology in the emerging field of regenerative medicine. 
The company is currently headquartered in Worcester, Massachusetts. 
For more information about the company visit 
http://www.advancedcell.com 

Forward-Looking Statements 

Statements in this news release regarding future financial and 
operating results, future growth in research and development 
programs, potential applications of our technology, opportunities 
for the and any other statements about the future expectations, 
beliefs, goals, plans, or prospects expressed by management 
constitute forward-looking statements within the meaning of the 
Private Securities Litigation Reform Act of 1995. Any statements 
that are not statements of historical fact (including statements 
containing the 
words "will," "believes," "plans," "anticipates," "expects," "estimat
es," and similar expressions) should also be considered to be 
forward-looking statements. There are a number of important factors 
that could cause actual results or events to differ materially from 
those indicated by such forward-looking statements, including: 
limited operating history, need for future capital, risks inherent 
in the development and commercialization of potential products, 
protection of our intellectual property, and economic conditions 
generally. Additional information on potential factors that could 
affect our results and other risks and uncertainties are detailed 
from time to time in the company's periodic reports, including the 
report on Form 10-QSB for the quarter ended September 30, 2005. 

Forward-looking statements are based on the beliefs, opinions, and 
expectations of the company's management at the time they are made, 
and the company does not assume any obligation to update its forward-
looking statements if those beliefs, opinions, expectations, or 
other circumstances should change.




http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.mail-archive.com/biotech-news@yahoogroups.com/
http://www.mail-archive.com/biotech-news@yahoogroups.com/maillist.html




http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/";>Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/";>Arizona High Tech</a>
 

Yahoo! Groups Links

<*> To visit your group on the web, go to:
    http://groups.yahoo.com/group/biotech-news/

<*> To unsubscribe from this group, send an email to:
    [EMAIL PROTECTED]

<*> Your use of Yahoo! Groups is subject to:
    http://docs.yahoo.com/info/terms/
 



Reply via email to